KeywayTM TCRm T-cell Engagers Discovery and Engineering: Fully Integrated Workflow from Target Idea to Development Candidate
Time: 12:30 pm
day: Conference Day 1
Details:
- TCRm antibody enable the targeting of intracellular proteins that have not been addressed by conventional cancer immunotherapies while avoiding the manufacturing and regulatory challenges of other TCR-based modalities
- Keyway TCRm Discovery is the industry leading service to deliver fully functional and highly-specific lead TCRm T cell engagers by integrating high quality pMHC generation, best-in-class antibody discovery capabilities, comprehensive AI/ML enabled specificity screening, and therapeutically-tailored functional testing
- Keyway TCRm Discovery is led by pioneering minds in the field of TCR-based therapies and the team has successfully executed many partner projects across a variety of targets and HLA alleles.
